Literature DB >> 25190699

Gene panel testing for inherited cancer risk.

Michael J Hall1, Andrea D Forman1, Robert Pilarski1, Georgia Wiesner1, Veda N Giri1.   

Abstract

Next-generation sequencing technologies have ushered in the capability to assess multiple genes in parallel for genetic alterations that may contribute to inherited risk for cancers in families. Thus, gene panel testing is now an option in the setting of genetic counseling and testing for cancer risk. This article describes the many gene panel testing options clinically available to assess inherited cancer susceptibility, the potential advantages and challenges associated with various types of panels, clinical scenarios in which gene panels may be particularly useful in cancer risk assessment, and testing and counseling considerations. Given the potential issues for patients and their families, gene panel testing for inherited cancer risk is recommended to be offered in conjunction or consultation with an experienced cancer genetic specialist, such as a certified genetic counselor or geneticist, as an integral part of the testing process.
Copyright © 2014 by the National Comprehensive Cancer Network.

Entities:  

Mesh:

Year:  2014        PMID: 25190699     DOI: 10.6004/jnccn.2014.0128

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  43 in total

Review 1.  Can genomic medicine improve financial sustainability of health systems?

Authors:  Christine Y Lu; Joshua P Cohen
Journal:  Mol Diagn Ther       Date:  2015-04       Impact factor: 4.074

2.  Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.

Authors:  Julia R Trosman; Christine B Weldon; Michael P Douglas; Allison W Kurian; R Kate Kelley; Patricia A Deverka; Kathryn A Phillips
Journal:  J Natl Compr Canc Netw       Date:  2017-02-10       Impact factor: 11.908

Review 3.  How Far Do We Go With Genetic Evaluation? Gene, Panel, and Tumor Testing.

Authors:  Filipa Lynce; Claudine Isaacs
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

4.  Update on multi-gene panel testing and communication of genetic test results.

Authors:  Sonya Reid; Tuya Pal
Journal:  Breast J       Date:  2020-07-08       Impact factor: 2.431

Review 5.  Using Genetics to Identify Hereditary Colorectal Polyposis and Cancer Syndromes in Your Patient.

Authors:  Carole Macaron; Brandie Heald; Carol A Burke
Journal:  Curr Gastroenterol Rep       Date:  2015-10

6.  Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.

Authors:  Phuong L Mai; Ana F Best; June A Peters; Rosamma M DeCastro; Payal P Khincha; Jennifer T Loud; Renée C Bremer; Philip S Rosenberg; Sharon A Savage
Journal:  Cancer       Date:  2016-08-06       Impact factor: 6.860

7.  Outcomes of retesting BRCA negative patients using multigene panels.

Authors:  Siddhartha Yadav; Ashley Reeves; Sarah Campian; Amy Paine; Dana Zakalik
Journal:  Fam Cancer       Date:  2017-07       Impact factor: 2.375

Review 8.  ATM mutations for surgeons.

Authors:  Sara A Mansfield; Robert Pilarski; Doreen M Agnese
Journal:  Fam Cancer       Date:  2017-07       Impact factor: 2.375

9.  Lower gastrointestinal neuroendocrine neoplasms associated with hereditary cancer syndromes: a case series.

Authors:  Trilokesh D Kidambi; Christina Pedley; Amie Blanco; Emily K Bergsland; Jonathan P Terdiman
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

10.  Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results.

Authors:  Angela R Bradbury; Linda J Patrick-Miller; Brian L Egleston; Michael J Hall; Susan M Domchek; Mary B Daly; Pamela Ganschow; Generosa Grana; Olufunmilayo I Olopade; Dominique Fetzer; Amanda Brandt; Rachelle Chambers; Dana F Clark; Andrea Forman; Rikki Gaber; Cassandra Gulden; Janice Horte; Jessica M Long; Terra Lucas; Shreshtha Madaan; Kristin Mattie; Danielle McKenna; Susan Montgomery; Sarah Nielsen; Jacquelyn Powers; Kim Rainey; Christina Rybak; Michelle Savage; Christina Seelaus; Jessica Stoll; Jill E Stopfer; Xinxin Shirley Yao
Journal:  J Natl Cancer Inst       Date:  2018-09-01       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.